Dermatologic infectious diseases in international travelers

Current Infectious Disease Reports

Volumn 6, Issue 1, 2004, Pages 54-62

  Wilson, Mary E ^a   Chen, Lin H ^b  

^a MOUNT AUBURN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALLOPURINOL; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTIMONY; ANTIMONY DERIVATIVE; BENZYL BENZOATE; CHLORAMPHENICOL; CHOLINE DERIVATIVE; CLARITHROMYCIN; DAPSONE; DOXYCYCLINE; FLUCONAZOLE; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; ITRACONAZOLE; IVERMECTIN; KETOCONAZOLE; LINDANE; MILTEFOSINE; PENTAMIDINE; PERMETHRIN; PLACEBO; PROTOZOAL VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STIBOGLUCONATE SODIUM; TETRACYCLINE; TIABENDAZOLE; UNINDEXED DRUG;

AFRICAN TRYPANOSOMIASIS; BURULI ULCER; CLINICAL FEATURE; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; DENGUE; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOGENICITY; LARVA MIGRANS; MORPHOLOGY; MYIASIS; NEMATODIASIS; NONHUMAN; PATIENT CARE; REVIEW; RICKETTSIOSIS; SCABIES; SKIN DEFECT; SKIN DISEASE; SKIN INFECTION; SKIN LEISHMANIASIS; SKIN SURGERY; THELAZIA; TRAVEL; TUNGIASIS;

EID: 5144225067     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0025-2     Document Type: Review

References (61)

1. Auerbach PS: Envenomation by aquatic invertebrates. In Wilderness Medicine, edn 4. Edited by Auerbach PS. St. Louis: Mosby; 2001:1450-1487.
2. Auerbach PS: Envenomation by aquatic vertebrates. In Wilderness Medicine, edn 4. Edited by Auerbach PS. St. Louis: Mosby; 2001:1488-1506.
3. Jelinek T, Maiwald H, Nothdurft, Loscher T: Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis 1994, 19:1062-1066.
4. Bruni M, Steffen R: Impact of travel-related impairments. J Travel Med 1997, 4:61.
5. Hill DR: Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000, 7:259-266.
6. Caumes E, Carriere J, Guermonprez G, et al.: Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Inject Dis 1995, 20:542-548.
7. Wilson ME: Skin problems in the traveler. Infect Dis Clin North Am 1998, 6:471-488.
8. Ryan ET, Wilson ME, Kain K: Illness after international travel. N Engl J Med 2002, 347:505-516.
9. Measles outbreak among internationally adopted children arriving in the United States, February-March 2001. MMWR Morb Mortal Wkly Rep 2002, 51:1115-1116.
10. Smoak BL, McClain JB, Brundage JF et al.: An outbreak of spotted fever rickettsiosis in U.S. Army troops deployed to Botswana. Emerg Infect Dis 1996, 2:217-221.
11. Raoult D, Fournier PE, Fenollar F, et al.: Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001, 344:1504-1510.
12. Jelinek T, Loscher T: Clinical features and epidemiology of tick typhus in travelers. J Travel Med 2001, 8:57-59.
13. Holman RC, Paddock CD, Curns AT, et al.: Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Inject Dis 2001, 184:1437-1444.
14. Cascio A, Colomba C, Di Rosa D, et al.: Efficacy and safety of clarithromycin as treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Inject Dis 2001, 33:409-411.
15. Purvis JJ, Edwards MS: Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 2000, 19: 871-874.
16. Watt G, Kantipong P, Johgsakul K, et al.: Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial. Lancet 2000, 356:1057-1061.
17. Jelinek T, Bisoffi Z, Bonazzi L, et al.: Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 2002, 8:634-635.
18. McGovern TW, Williams W, Fitzpatrick JE, et al.: Cutaneous manifestations of African trypanosomiasis. Arch Dermatol 1995, 131:1178-1182.
19. Wilson ME, Chen LH: Dengue in the Americas. Dengue Bull 2002, 26:44-61.
20. Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11:480-496.
21. Rios-Fabra A, Moreno AR, Isturiz RE: Fungal infection in Latin American countries. Infect Dis Clin North Am 1994, 8: 129-154.
22. Stevens DA: Coccidioidomycosis. N Engl J Med 1995, 332:1077-1082.
23. Kim A, Parker SS: Coccidioidomycosis: case report and update on diagnosis and management. J Am Acad Dermatol 2002, 46:743-747.
24. Cairns L, Blyth D, Kao A, et al.: Outbreak of coccidioidomycosis in Washington State residents returning from Mexico. Clin Infect Dis 2000, 30:61-64.
25. Belli A, Barcia D, Palacios X, et al.: Widespread atypical cutaneous leishmaniasis caused by Leishmania (L.) chagasi in Nicaragua. Am J Trop Med Hyg 1999, 61:380-385.
26. Wortman GW, Aronson NE, Miller RS, et al.: Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 2000, 31:199-201.
27. Schubach A, Haddad F, Oliveira-Neto MP, et al.: Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998, 178:911-914.
28. Herwaldt BL: Leishmaniasis. Lancet 1999, 354:1191-1199.
29. Ramirez JR, Agudelo S, Muskus C, et al.: Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol 2000, 38:3768-3773.
30. Berman J: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997, 24:684-703.
31. Alrajhi AA, Ibrahim EA, De Vol EB, et al.: Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002, 346:891-895.
32. JhaTK, Sundar S, Thakur CP, et al.: Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999, 341:1795-1800.
33. Kamhawi S, Bilkaid Y, Modi G, et al.: Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 2000, 290:1351-1354.
34. Armijos RX, Weigel MM, Aviles H, et al.: Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow up. J Infect Dis 1998, 177:1352-1357.
35. Urbanization: an increasing risk factor for leishmaniasis. Wkly Epidemiol Rec 2002, 77:365-372.
36. Kroeger A, Avila EV, Morison L: Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomized trial. BMJ 2002, 325:810-813.
37. Semret M, Koromihis G, MacLean JD, et al.: Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. Am J Trop Med Hyg 1999, 61:689-693.
38. Veitch MG, Johnson PD, Flood PE, et al.: A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiol Inject 1997, 119:313-318.
39. Marsollier L, Robert R, Aubry J, et al.: Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 2002, 68:4623-4628.
40. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K: Mycobacterium ulcerans infection. Lancet 1999, 354:1013-1018.
41. Espey DK, Djomand C, Diomande I, et al.: A pilot study of treatment of Buruli ulcer with rifampin and dapsone. Int J Infect Dis 2002, 6:60-65.
42. Mve-Obiang A, Lee RE, Portaels F, Small PL: Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 2003, 71: 774-783.
43. Rusnak JM, Lucey DR: Clinical gnathostomiasis: case report and review of the English-language literature. Clin Infect Dis 1993, 16:33-50.
44. Puente S, Garate T, Grobusch MP, et al.: Two cases of imported gnathostomiasis in Spanish women. Eur J Clin Microbiol Infect Dis 2002, 21:617-620.
45. Del Giudice P, Dellamonica P, Durant J, et al.: A case of gnathostomiasis in a European traveler returning from Mexico. Br J Dermatol 2001, 145:487-489.
46. Chappuis F, Farinelli T, Loutan L: Ivermectin treatment of a traveler who returned from Peru with cutaneous gnathostomiasis. Clin Infect Dis 2001, 33:E17-L19.
47. Grobusch MP, Bergmann F, Teichmann D, Klein E: Cutaneous gnathostomiasis in a woman from Bangladesh. Int J Inject Dis 2000, 4:51-54.
48. Rojas-Molina N, Pedraza-Sanchez S, Torres-Bibiano B, et al.: Gnathostomiasis, an emerging foodborne zoonotic disease in Acapulco, Mexico. Emerg Infect Dis 1999, 5:264-266.
49. Nontasut P, Bussaratid V, Chullawichit S, et al.: Comparison of ivermectin and albendazole treatment for gnathostomiasis. Southeast Asian J Trop Med Public Health 2000, 31: 374-377.
50. Bouchaud O, Houze S, Schiemann R, et al.: Cutaneous larva migrans in travelers; a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis 2000, 31: 493-498.
51. Blackwell V, Vega-Lopez F: Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveler. Br J Dermatol 2001, 145:434-437.
52. Tremblay A, MacLean JD, Gyorkos T, MacPherson DW: Outbreak of cutaneous larva migrans in a group of travelers. Trop Med Int Health 2000, 5:330-334.
53. Caumes E: Treatment of cutaneous larva migrans. Clin Infect Dis 2000, 30:811-814.
54. Van den Enden E, Stevens A, Van Compel A: Treatment of cutaneous larva migrans. N Engl J Med 1998, 339: 1246-1247.
55. Del Mar Saez-de-Ocariz M, McKinster CD, Orozco-Covarrubias L, et al.: Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin. Clin Dermatol 2002, 27:264-267.
56. Boggild AK, Keystone JS, Kain KC: Furuncular myiasis: a simple and rapid method for extraction of intact Dermatobia hominis larvae. Clin Infect Dis 2002, 35:336-368.
57. Pereira MC, Leite VH, Leite AC: Experimental skin lesions from larvae of the botfly Dermatobia hominis. Med Vet Entomol 2001, 15:22-27.
58. Veraldi S, Carrera C, Schianchi R: Tungiasis has reached Europe. Dermatology 2000, 201:382.
59. Fein H, Naseem S, Witte DP, et al.: Tungiasis in North America: a report of 2 cases in internationally adopted children. J Pediatr 2001, 139:744-746.
60. Wendel K, Rompalo A: Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2002, 35(Suppl 2):S146-S151.
61. Usha V, Gopalakrishnan Nair TV: A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000, 42:236-240.